Official recipe · Browser tasks
Collect upcoming clinical-trial readouts
Source-backed example. Practical decision guidance is proposed and untested; this is not a full implementation guide.
The problem
Upcoming trial readouts are difficult to track when sponsor, drug, phase and timing details must be gathered across calendar entries.
Agent job
Traverse a trial-results calendar for a specified date range and extract the listed study details.
Expected output
A table of sponsors, drugs, indications, phases and expected readout dates.
Where this framing comes from
- Core problem: Editorial purpose framing
- Agent job: Editorial purpose framing
- Expected output: Editorial purpose framing
- Relevant job roles: Editorial purpose framing
- Benefit type: Editorial purpose framing
Editorial framing and outcome limits
Describes the task’s purpose and intended output; measured benefit, safe unsupervised operation and successful delivery are not established by this framing.
Editorial synthesis based on the linked source. This framing does not add evidence of successful delivery or results.
Case-specific decision guidance · untested
Case-specific decision guidance and first checks are original proposals. The linked source supports the attributed task; this added guidance has not been executed.
Read the attributed source evidence and original caveats below ↓
Why use this
A researcher following trial readouts may find dates expressed as quarters, ranges or tentative milestones across calendar entries. A tidy table can overstate certainty if it converts those indications into exact deadlines.
This job could collect the listed details while preserving timing precision and source dates. The reader can see which entries need follow-up without interpreting a calendar expectation as a confirmed result or a prediction of trial success.
Why an agent / simpler alternative
- Useful judgment
Normalize study identifiers and timing language while retaining ambiguity, revisions and distinctions between milestones.
- Simpler alternative
Use the calendar's built-in filters when a short date-range view is sufficient.
- Unsuitable when
The output would guide treatment or investment decisions without qualified review or claim confirmed results before publication.
Proposed inputs
- Name
Readout brief
- Owner
Research owner
- Minimum scope
Date range, scope and desired table fields
- Quality check
Define which milestone types belong
- Name
Calendar excerpts
- Owner
Permitted source
- Minimum scope
Sponsor, drug, indication, phase and stated timing
- Quality check
Record source date and distinguish estimates from announcements
Access and setup — proposed or unknown
- Proposed minimum
Review fictional calendar entries and design a table; no live site traversal, subscriptions or data purchase.
- Compatibility unknowns
Current calendar access, completeness, update cadence and runtime compatibility are unknown.
- External actions requiring approval
Paid access, external sharing or recurring alert subscriptions requires authorization.
Expected deliverable and review checks
- Proposed artifact
Readout-table candidate with study identifiers, verbatim timing precision, source dates and unresolved entries.
- Critical checks
Keep quarter/range labels; distinguish study completion from readout; preserve conflicting dates and unknown phase details.
- Missing output evidence
This overlay adds no new output inspection, execution or validation; consult the referenced canonical source outcome limits.
Failure signals and proposed responses
- Signal
A quarter estimate becomes a specific date
- Why it matters
The table invents schedule precision
- Proposed response
Retain the original interval and label it expected.
- Signal
Similar drug names merge different studies
- Why it matters
The timeline points to the wrong trial
- Proposed response
Match sponsor, indication and study identity before combining.
Effort and cost — unknown
- Setup work
Define milestone scope and timing conventions.
- Ongoing review
Researcher checks revisions before consequential use.
- Unknowns
Schedule reliability, source coverage, licensing and research effort are unknown.
First check — proposed, unexecuted
- Status
proposed_unexecuted
- Synthetic fixture
Invent four entries with exact, quarter-based, revised and missing timing; include two similarly named study assets.
- Acceptance checks
Preserve precision; separate studies; flag revisions; infer no result or clinical outcome.
- Stop conditions
Stop if identity or milestone meaning cannot be resolved without guessing.
Limits
A readout calendar cannot establish actual disclosure timing, trial efficacy, regulatory outcomes or investment suitability.
Editorial candidate. This is source-backed reporting or a documented workflow. BotCurrent has not independently tested this task. A proposed Canadian adaptation is not evidence of a Canadian deployment or compliance certification.
Original source
https://browser-use.com/showcase/clinical-trial-results ↗Attributed to: Browser Use
Official recipe- Original action type
- browser_action
- What the source supports
- Traverse a trial-results calendar for a date range and tabulate sponsor, drug, indication, phase and expected timing.
- Source outcome limits
- This official recipe describes a procedure; it does not prove successful execution or independently reproduced results.
- Evidence attribution caveat
- This official recipe describes a procedure; it does not prove successful execution or independently reproduced results.
- Source approval description
- Not specified.
- Named tools
- Browser Use; biopharmcatalyst.com
- Model or version
- Unknown
- Publication date
- Unknown
- Source last checked
- 2026-10-14
- Demonstrated in Canada
- Unknown
- Canadian availability
- unverified
- Proposed Canadian adaptation
- Keep source dates and uncertainty; assess Canadian trial and issuer relevance separately without investment recommendations.
- Recommended approval boundaries
- Approve account access and any personal-data disclosure. Review before purchases, bookings, messages, archive requests, uploads or publication. Keep research read-only where possible.